Researchers

  • Male

Drs. A. Sutterland MD

Position: PhD student
Main activities: Patient care, Research, Teaching
Specialisation: Psychiatrist
foto
Focus of research:

- Psychoneuroimmunology, with special focus on the association between Toxoplasma gondii and (abberant) immunological reaction in people with (emerging) psychosis.

- Relationship between cardiac arrythmias and psychosis

- Cardiovascular complications, metabolism, aging and severe mental illness

 

AMC themes: Infection & Immunity, Neurological & Psychiatric Disorders
Departments: Psychiatry: Adult Psychiatry
Hagen JM, Sutterland AL, Koeter MW, Lutter R, Cohen D, de Haan L, Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk. J CLIN PSYCHIAT 2017;-:- [PubMed]
van der Doef TF, de Witte LD, Sutterland AL, Jobse E, Yaqub M, Boellaard R, de Haan L, Eriksson J, Lammertsma AA, Kahn RS, van Berckel BNM, In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis. NPJ SCHIZOPHR 2016;2:16031 [PubMed]
Sutterland AL, Fond G, Kuin A, Koeter MWJ, Lutter R, van Gool T, Yolken R, Szoke A, Leboyer M, de Haan L, Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. ACTA PSYCHIAT SCAND 2015;132 (3):161-179 [PubMed]
Jagt YQ, Sutterland AL, Meijer JH, Oudijn MS, Kemperman PM, Vulink NCC, de Haan L, Parasieten- of infestatiewaan: een therapeutische uitdaging. NED TIJDSCHR GENEESKD 2014;158:A7548 [PubMed]
Kroon JS, Wohlfarth TD, Dieleman J, Sutterland AL, Storosum JG, Denys D, de Haan L, Sturkenboom MCJM, Incidence rates and risk factors of bipolar disorder in the general population: a population-based cohort study. BIPOLAR DISORD 2013;15 (3):306-313 [PubMed]
Sutterland AL, Dieleman J, Storosum JG, Voordouw BAC, Kroon J, Veldhuis J, Denys DAJP, de Haan L, Sturkenboom MCJM, Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort study. SOC PSYCH PSYCH EPID 2013;48 (9):1357-1365 [PubMed]
Nieman DH, Sutterland AL, Otten J, Becker HE, Drent ML, van der Gaag M, Birchwood M, de Haan L, Treating prolactinoma and psychosis: medication and cognitive behavioural therapy. BMJ CASE REP 2011;2011:bcr0720103185 [PubMed]
Key publications

Sutterland AL, Fond G, Kuin A, Koeter MWJ, Lutter R, van Gool T, Yolken R, Szoke A, Leboyer M, de Haan L, Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. ACTA PSYCHIAT SCAND 2015;132 (3):161-179 [PubMed]
Hagen JM, Sutterland AL, Koeter MW, Lutter R, Cohen D, de Haan L, Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk. J CLIN PSYCHIAT 2017;-:- [PubMed]
Sutterland AL, Dieleman J, Storosum JG, Voordouw BAC, Kroon J, Veldhuis J, Denys DAJP, de Haan L, Sturkenboom MCJM, Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort study. SOC PSYCH PSYCH EPID 2013;48 (9):1357-1365 [PubMed]
van der Doef TF, de Witte LD, Sutterland AL, Jobse E, Yaqub M, Boellaard R, de Haan L, Eriksson J, Lammertsma AA, Kahn RS, van Berckel BNM, In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis. NPJ SCHIZOPHR 2016;2:16031 [PubMed]
Kroon JS, Wohlfarth TD, Dieleman J, Sutterland AL, Storosum JG, Denys D, de Haan L, Sturkenboom MCJM, Incidence rates and risk factors of bipolar disorder in the general population: a population-based cohort study. BIPOLAR DISORD 2013;15 (3):306-313 [PubMed]


All Publications

Research programmes
Other research related activities
  • None reported
Current research funding
  • None reported